These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21460864)

  • 21. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells.
    Burger D; Touyz RM
    J Am Soc Hypertens; 2012; 6(2):85-99. PubMed ID: 22321962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years.
    Kalayoglu-Besisik S; Yenerel MN; Caliskan Y; Ozturk S; Besisik F; Sargin D
    Transplant Proc; 2005 Jun; 37(5):2285-9. PubMed ID: 15964400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation.
    Leimi L; Koski JR; Kilpivaara O; Vettenranta K; Lokki AI; Meri S
    Front Immunol; 2023; 14():1249958. PubMed ID: 37771589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.
    Majhail NS; Parks K; Defor TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1038-46. PubMed ID: 17067910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation.
    Cooke KR; Jannin A; Ho V
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):23-32. PubMed ID: 18162218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
    Najima Y; Ohashi K; Miyazawa M; Nakano M; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
    Am J Hematol; 2009 May; 84(5):298-301. PubMed ID: 19338041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
    Tefferi A; Kumar S; Wolf RC; Lacy MQ; Inwards DJ; Gloor JM; Albright RC; Kamath PS; Litzow MR
    Bone Marrow Transplant; 2001 Nov; 28(10):997-9. PubMed ID: 11753559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
    Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
    Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial Dysfunction in Hematopoietic Cell Transplantation.
    Palomo M; Diaz-Ricart M; Carreras E
    Clin Hematol Int; 2019 Mar; 1(1):45-51. PubMed ID: 34595410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of tissue factor bearing microparticles as biomarkers in allogeneic stem-cell transplantation.
    De Rop C; Stadler M; Buchholz S; Eisert R; Ganser A; Trummer A
    Transplantation; 2011 Aug; 92(3):351-8. PubMed ID: 21681142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial cell dysfunction in microvasculature: relevance to disease processes.
    Oda M; Han JY; Nakamura M
    Clin Hemorheol Microcirc; 2000; 23(2-4):199-211. PubMed ID: 11321441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Fas/FasL system and endothelial cell microparticles are involved in endothelial damage in acute graft-versus-host disease: a clinical analysis.
    Wu Q; Chen H; Fang J; Xie W; Hong M; Xia L
    Leuk Res; 2012 Mar; 36(3):275-80. PubMed ID: 21917312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention and treatment of hepatic veno-occlusive disease].
    Carreras E
    Gastroenterol Hepatol; 2011 Nov; 34(9):635-40. PubMed ID: 21571396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sinusoidal obstruction syndrome.
    Rubbia-Brandt L
    Clin Liver Dis; 2010 Nov; 14(4):651-68. PubMed ID: 21055688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
    Moscardó F; Sanz GF; de La Rubia J; Jiménez C; Saavedra S; Regadera A; Andreu R; García I; Plumé G; Martínez J; Martín G; Jarque I; Sanz MA
    Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of radiation injury.
    MacVittie TJ
    Stem Cells; 1997; 15 Suppl 2():263-8. PubMed ID: 9368312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a reproducible rat model of hepatic veno-occlusive disease.
    DeLeve LD; McCuskey RS; Wang X; Hu L; McCuskey MK; Epstein RB; Kanel GC
    Hepatology; 1999 Jun; 29(6):1779-91. PubMed ID: 10347121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation.
    Ringdén O; Remberger M; Lehmann S; Hentschke P; Mattsson J; Klaesson S; Aschan J
    Bone Marrow Transplant; 2000 May; 25(9):993-6. PubMed ID: 10800069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study.
    Tanikawa S; Mori S; Ohhashi K; Akiyama H; Sasaki T; Kaku H; Hiruma K; Matsunaga T; Morita T; Sakamaki H
    Bone Marrow Transplant; 2000 Oct; 26(8):881-6. PubMed ID: 11081389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.